As of 2025-07-06, the Relative Valuation of GeneTether Therapeutics Inc (GTTX.CN) is 0.10 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of GeneTether Therapeutics Inc based on Relative Valuation is 0.1%.
The range of the Relative Valuation is 0.10 - 0.10 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -8.0x - -8.0x | -8.0x |
| Fair Price | 0.10 - 0.10 | 0.10 |
| Upside | 0.1% - 0.1% | 0.1% |
| Date | P/E |